Clinical Trials Browser

Enrolling by invitation × Carcinoma, Non-Small-Cell Lung × 90 days × Clear all

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms, Melanoma, Neoplasm Metastasis, Neoplasms

NCT06730685 2026-02-12

PHILUCA

Enrolling by invitation

160 enrolled

Thoracic

Cachexia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma, Sarcopenia

NCT06250777 2026-02-09

ELPIS

Phase 2 Enrolling by invitation

27 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06332131 2026-02-09

Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature

Enrolling by invitation

25 enrolled

BreastThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Cardiotoxicity

NCT07373951 2026-01-29

DL-DriverBM

Enrolling by invitation

380 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT06370416 2026-01-28

the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib

Phase 2 Enrolling by invitation

41 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01385722 2025-12-26

Molecular Analysis of Thoracic Malignancies

Enrolling by invitation

1,000 enrolled

Other solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Mesothelioma, Thymoma, Thymus Neoplasms

NCT07301983 2025-12-24

LALC

Enrolling by invitation

130 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Clinical Trials

Harvesting Cells for Experimental Cancer Treatments

PHILUCA

ELPIS

Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature

DL-DriverBM

the Prevention of Bone Marrow Suppression Caused by Chemotherapy in Advanced NSCLC With Trilaciclib

Molecular Analysis of Thoracic Malignancies

LALC